1. Ahmann, D. L., Payne, W. S., Scanlon, P. W., O'Fallon, J. R., Bisel, H. F., Hahn, R. G., Edmondson, J. H., Ingle, J. N., Frytak, S., O'Connell, M. J., and Rubin, J., 1978, Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide and prednisone with or without radiation, after mastectomy for breast cancer. Lancet, 1, 983.
2. Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., Delena, M., Tancini, G., Bajetta, E., Musumeci, R., and Veronesi, U., 1976, Combination chemotherapy as an adjuvant treatment in operable breast cancer. New England Journal of Medicine, 294, 405.
3. Bonadonna, G., and Valagussa, P., 1981, Dose-response effect of adjuvant chemotherapy in breast cancer. New England Journal of Medicine, 304, 10?15.
4. Bonadonna, G., Valagussa, P., Rossi, A., et al., 1981, Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes. The Milan Experience. Adjuvant therapy of cancer, III, edited by S. E. Salmon and S. E. Jones (New York: Grune & Stratton), pp. 435?445.
5. Buzdar, A. Ü., Blumenschein, G. R., Gutterman, J. U., et al., 1979, Postcuratlve adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG FAC-BCG. Journal of the American Medical Association, 242, 1509?1513.